Benefits
Traditional cough and chest herb
Hyssop tea has a long folk history as an expectorant, a herb taken to help loosen mucus, and for colds and cough. A US government liver-safety reference describes it as a widely used herb. This use rests on tradition, not on trials of hyssop tea in people.
Breathing measures in one placebo-controlled syrup trial
In 60 adults with mild to moderate asthma who kept their usual inhalers, 4 weeks of hyssop syrup improved lung function and symptom scores in those with a productive cough, while those with a dry cough got worse and 5 more dry-cough users dropped out. Results came only from subgroups formed after the trial, with no whole-group result.
Cough scores with a seven-herb syrup in children
In 46 children aged 7 to 12 with intermittent asthma, a 5-day syrup of seven herbs including hyssop, started at the first sign of a cold, lowered cough severity and night waking versus placebo but did not change wheezing, peak flow, attacks or rescue medicine use. The effect cannot be attributed to hyssop.
Gut muscle relaxation in lab tissue
In isolated guinea pig and rabbit intestine, hyssop essential oil and its ketone isopinocamphone relaxed contractions in a concentration-dependent way. This is tissue-bath work only and has not been tested in living animals or people, and the oil itself should not be swallowed.
Carbohydrate digestion enzymes in rodent research
Hyssop leaves contain glycosides that block alpha-glucosidase, a gut enzyme that breaks down starch and sugar. In mice given an oral hyssop extract before a sugar load, the early rise in blood sugar was smaller. This is animal work only, with no human data.
Stomach lining in a rat study
In rats, an ethanol extract of hyssop leaves given by mouth for 10 days before a high dose of the painkiller indomethacin lowered the stomach injury score, thickened the protective mucus layer and raised antioxidant enzymes. These are animal findings only and have not been tested in people.
Mechanism of action
Pinocamphone ketones block GABA-A receptors
The two main ketones of hyssop oil (cis- and trans-3-pinanone, the pinocamphone pair) and the oil itself block the GABA-A receptor, the brain's main calming receptor, in mouse brain membranes, and cause convulsions in mice given injections. This explains the seizure risk of the essential oil. Liver enzymes, including human CYP3A4, break the ketones down.
Alpha-glucosidase inhibiting compounds in the leaves
Glycosides from dried hyssop leaves inhibit alpha-glucosidase. Hyssop extracts slowed the release of glucose from sucrose and maltose in rat gut tissue but did not block the uptake of glucose itself. This is shown in lab and animal work only.
Airway immune markers in mice
In a mouse allergen-challenge model, hyssop-treated mice had eosinophil levels in lung fluid and blood IgE and IgG levels close to those of normal mice. These are animal immune markers, not outcomes in people.
Clinical trials
Randomized, triple-blind, placebo-controlled trial of an Iranian hyssop syrup added to usual asthma treatment for 4 weeks; outcomes were analyzed in subgroups defined after the trial. (Daneshfard et al. 2024, Tanaffos)
60 adults with mild to moderate persistent asthma who completed the trial (70 enrolled), 30 per group, taking hyssop syrup 5 mL twice daily (each 5 mL from 6 g of dried herb) or sugar syrup.
No result for the whole group was reported. In people with a productive cough, FEV1 rose by about 20 percentage points versus almost no change on placebo, with better symptom-control scores at week 4. In people with a dry cough, FEV1 fell by about 8 points and wheezing and week 4 symptom-control scores worsened; their symptom-control score rose between week 4 and week 8, after the syrup ended. Five other hyssop users, all with a dry cough, dropped out because of more coughing or breathlessness and were not analyzed. Thirst, dry mouth and throat irritation were reported.
Double-blind, randomized, placebo-controlled trial of a traditional herbal syrup of chamomile, marshmallow, mallow, hyssop, maidenhair fern, licorice and jujube, given for 5 days from the start of a cold. (Javid et al. 2019, Avicenna J Phytomed)
46 children aged 7 to 12 with intermittent asthma at the onset of a viral cold, taking 5 mL three times daily or placebo.
Cough severity (p=0.049) and night awakenings (p=0.029) were lower than on placebo. Wheezing, peak flow, asthma attacks, school absence and use of rescue inhalers or oral steroids did not differ. No adverse effects were seen. Because seven herbs were combined, the result says nothing about hyssop alone.
French clinical case series of poisonings from commercial essential oils, with an electrocortical study of sage and hyssop oils in rats. (Millet et al. 1981, Clin Toxicol)
Eight people poisoned by commercial essences of sage, hyssop, thuja or cedar; unanesthetized laboratory rats given graded doses of commercial hyssop and sage oils, with repeated low doses given by daily injection.
Tonic-clonic convulsions were the main symptom in the human cases. In rats, hyssop oil was more potent than sage oil: convulsions appeared above 0.13 g/kg and were lethal above 1.25 g/kg, and repeated daily injections of low doses built up to seizures. The authors attributed hyssop oil's toxicity to pinocamphone.
Case reports from a Swiss university neurology department with a survey of the literature on convulsant plant oils. (Burkhard et al. 1999, J Neurol)
Three previously healthy people, two adults and one child, whose seizures were linked to absorbing several essential oils used for therapeutic purposes (the abstract does not give the route).
The two adults each had a single generalized tonic-clonic seizure and the child had a generalized tonic status; no other cause was found, and the child fared less well. The literature survey lists hyssop oil among 11 powerful plant convulsants because of ketones such as pinocamphone. The abstract does not say which oils each patient used.